Key Quantitative Figures
- Total equity shares allotted: 18,12,859 shares of face value ₹4 each
- Total amount raised upon conversion: ₹12,69,00,130
- Balance consideration received (75% of warrant price): ₹9,51,75,095.50
- Upfront consideration previously paid (25% of warrant price): ₹3,17,25,034.50
- Issue price per share: ₹70 (including premium of ₹66 per share)
- Post-allotment issued and paid-up share capital: ₹10,37,68,460
- Post-allotment total equity shares: 2,59,42,115 shares of ₹4 each
Dates of Action
- Extraordinary General Meeting approval: June 27, 2025
- BSE in-principle approval: September 12, 2025
- Board approval for allotment: September 26, 2025
- Board meeting for conversion decision: August 20, 2026 (commenced 11:30 AM, ended 12:50 PM)
- Warrant conversion tenure valid until: March 25, 2027
Parties Involved
Allottees (Warrant Holders):
1. Hasanain Shaukatali Mewawala (Promoter) - 1,41,429 shares
2. Aegis Investment Fund PCC (Non-Promoter) - 14,14,285 shares
3. Mumtaz sajjadhussien Nathani (Non-Promoter) - 85,715 shares
4. Neelam Salim Bachooali (Non-Promoter) - 85,715 shares
5. Yasmin Merchant (Non-Promoter) - 85,715 shares
Capital Structure Impact
- Pre-conversion share capital: Not explicitly stated in disclosure
- Post-conversion share capital: ₹10,37,68,460 consisting of 2,59,42,115 equity shares of ₹4 each
- The new equity shares rank pari-passu with existing equity shares
- Allotment made in dematerialized form
Additional Details
- The share warrants were fully convertible with no warrants pending for conversion
- The preferential allotment was made on a private placement basis
- The warrant issue price was ₹70 per warrant
- Balance consideration of ₹52.50 per warrant (75% of issue price) was received for conversion